Calypte Selects Manufacturing Partner in China

Manufacturing facilities in China for the company's fast HIV test have been announced by Calypte Biomedical Corp. (Alameda, CA, USA). Calypte has selected Beijing Tiantan Biological Products Co., Ltd. (BTBP), a biotechnology company whose parent is the National Vaccine & Serum Institute.

Calypte will be responsible for supplying technology, manufacturing and quality control equipment, expertise, technical assistance, and technical support while BTBP supplies the manufacturing facilities where the Rapid HIV-1/2 antibody tests will be produced. Calypte will be in charge of day-to-day operations.

"We are very pleased with this memorandum of understanding whereby BTBP established the long-term cooperation relationship with Calypte and the new cooperation company will manufacture Calypte's HIV rapid products, as BTBP sees a great market potential for Calypte's Rapid HIV-1/2 antibody tests in the People's Republic of China as well as other parts of the world,” said Ni Daoming, chairman of BTBP.

"Our relationship with BTBP is expected to greatly accelerate our entry into the Chinese market,” said Dr. J. Richard George, president and CEO of Calypte.




Related Links:
Calypte